Among them, only PRKCB was significantly downregulated in NSCLC tissues, and its high expression was significantly associated with better prognosis (Figures 4D, E), thus it was identified as the key target gene of miR-4664-3p. The gene discussed is PRKCB; the disease is non-small cell lung carcinoma.